Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Urol. Nov 24, 2014; 3(3): 351-357
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.351
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.351
Table 1 Clinicopathological parameters for patients with seminomatous testicular germ cell cancer n (%)
| Variables | Carcinoma (n = 11) | Control (n = 5) |
| Age in years mean (range) | 40.58 (33-53) | 30.75 (24-42) |
| Pathological stage | ||
| pT1 | 7 (63.6) | NA |
| pT2 | 2 (18.2) | NA |
| pT3 | 2 (18.2) | NA |
| Lymphnode metastasis | ||
| cNx | 1 (9.1) | NA |
| cN0 | 7 (63.6) | NA |
| cN1 | 1 (9.1) | NA |
| cN2 | 2 (18.2) | NA |
| M-stage | ||
| cMx | 1 (9.1) | NA |
| cM0 | 10 (90.9) | NA |
| Tumor marker | ||
| HCG increased | 5 (45.5) | NA |
| LDH increased | 3 (45.5) | NA |
| AFP increased | 0 (0) | NA |
| Clinical tumor stage | ||
| CSIA | 5 (45.5) | NA |
| CSIS | 3 (27.3) | NA |
| CSIIB | 1 (9.1) | NA |
| CSIIC | 2 (18.2) | NA |
- Citation: Fischer N, Göke F, Kahl P, Splittstößer V, Lankat-Buttgereit B, Müller SC, Ellinger J. Programmed cell death protein 4 expression in renal cell carcinoma, penile carcinoma and testicular germ cell cancer. World J Clin Urol 2014; 3(3): 351-357
- URL: https://www.wjgnet.com/2219-2816/full/v3/i3/351.htm
- DOI: https://dx.doi.org/10.5410/wjcu.v3.i3.351